These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Peripheral effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and its main metabolite 1-methyl-4-phenylpyridinium ion (MPP+) in the rat. Algeri S; Ambrosio S; Garofalo P; Gerli P Eur J Pharmacol; 1987 Sep; 141(2):309-12. PubMed ID: 3500067 [TBL] [Abstract][Full Text] [Related]
7. The toxic actions of MPTP and its metabolite MPP+ are not mimicked by analogues of MPTP lacking an N-methyl moiety. Bradbury AJ; Costall B; Domeney AM; Testa B; Jenner PG; Marsden CD; Naylor RJ Neurosci Lett; 1985 Oct; 61(1-2):121-6. PubMed ID: 2417166 [TBL] [Abstract][Full Text] [Related]
8. Selective accumulation of MPP+ in the substantia nigra: a key to neurotoxicity? Irwin I; Langston JW Life Sci; 1985 Jan; 36(3):207-12. PubMed ID: 3871240 [TBL] [Abstract][Full Text] [Related]
9. Astrocytes convert the parkinsonism inducing neurotoxin, MPTP, to its active metabolite, MPP+. Ransom BR; Kunis DM; Irwin I; Langston JW Neurosci Lett; 1987 Apr; 75(3):323-8. PubMed ID: 3495754 [TBL] [Abstract][Full Text] [Related]
10. 1-methyl-4-phenylpyridine is neurotoxic to the nigrostriatal dopamine pathway. Bradbury AJ; Costall B; Domeney AM; Jenner P; Kelly ME; Marsden CD; Naylor RJ Nature; 1986 Jan 2-8; 319(6048):56-7. PubMed ID: 3484542 [TBL] [Abstract][Full Text] [Related]
11. [Evaluation of the capability of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and pyridine derivatives to evoke parkinsonism]. Lermontiva NN; Soliakov LS; Bachurin SO; Tkachenko SE; Serkova TP Biull Eksp Biol Med; 1989 Jun; 107(6):699-701. PubMed ID: 2790166 [TBL] [Abstract][Full Text] [Related]
12. Studies on the acute and long-term changes in dopamine and noradrenaline metabolism in mouse brain following administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Pileblad E; Carlsson A Pharmacol Toxicol; 1988 Apr; 62(4):213-22. PubMed ID: 3260379 [TBL] [Abstract][Full Text] [Related]
13. N-methyl-4-phenylpyridine (MMP+) together with 6-hydroxydopamine or dopamine stimulates Ca2+ release from mitochondria. Frei B; Richter C FEBS Lett; 1986 Mar; 198(1):99-102. PubMed ID: 3082673 [TBL] [Abstract][Full Text] [Related]
14. The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease. Jenner P; Marsden CD J Neural Transm Suppl; 1986; 20():11-39. PubMed ID: 3091760 [TBL] [Abstract][Full Text] [Related]
15. Behavioral and biochemical changes following acute administration of MPTP and MPP+. Tadano T; Satoh N; Sakuma I; Matsumura T; Kisara K; Arai Y; Kinemuchi H Life Sci; 1987 Mar; 40(13):1309-18. PubMed ID: 2436017 [TBL] [Abstract][Full Text] [Related]
16. Histochemistry of MPTP oxidation in the rat brain: sites of synthesis of the parkinsonism-inducing toxin MPP+. Nakamura S; Vincent SR Neurosci Lett; 1986 Apr; 65(3):321-5. PubMed ID: 3487052 [TBL] [Abstract][Full Text] [Related]
18. Model study on the bioreduction of paraquat, MPP+, and analogs. Evidence against a "redox cycling" mechanism in MPTP neurotoxicity. Frank DM; Arora PK; Blumer JL; Sayre LM Biochem Biophys Res Commun; 1987 Sep; 147(3):1095-104. PubMed ID: 3499150 [TBL] [Abstract][Full Text] [Related]
19. 4-Phenylpyridine (4PP) and MPTP: the relationship between striatal MPP+ concentrations and neurotoxicity. Irwin I; Langston JW; DeLanney LE Life Sci; 1987 Feb; 40(8):731-40. PubMed ID: 3492652 [TBL] [Abstract][Full Text] [Related]
20. Effects of the parkinsonism-inducing neurotoxin MPTP and its metabolite MPP+ on sympathetic adrenergic nerves in mouse iris and atrium. Luthman J; Jonsson G Med Biol; 1986; 64(2-3):95-102. PubMed ID: 3489145 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]